Skip to main content
. 2016 Nov 7;58(1):90–98. doi: 10.3349/ymj.2017.58.1.90

Table 2. Baseline Laboratory Findings between the Two Groups.

Variables Entire patients Matched patients
Diltiazem (n=842) Dual (n=1899) p value Diltiazem (n=811) Dual (n=811) p value
Total cholesterol (mg/dL) 179±36 182±37 0.092 179±37 179±37 0.856
HDL cholesterol (mg/dL) 50.7±13.2 51.0±13.0 0.519 50.3±13.0 51.0±13.1 0.337
LDL cholesterol (mg/dL) 111±33 115±33 0.010 111±33 112±33 0.666
Triglyceride (mg/dL) 126±84 133±91 0.087 127±85 122±86 0.340
High-sensitive CRP (mg/L) 2.6±9.68 2.9±11.6 0.610 2.6±9.76 3.6±15.1 0.271
Fasting blood glucose (mg/dL) 100±22 103±23 0.006 101±22 102±23 0.139
Hemoglobin A1c (%) 5.9±0.7 6.0±0.9 0.027 5.9±0.7 6.0±0.8 0.250
Insulin (ng/dL) 9.83±4.5 9.98±6.9 0.857 9.87±4.6 10.6±8.1 0.453
Hemoglobin (mg/dL) 13.3±1.4 13.8±1.5 <0.001 13.3±1.4 13.5±1.5 0.005
Hematocrit (%) 39.2±4.2 40.7±4.4 <0.001 39.2±4.2 39.9±4.4 0.005
Creatinine (mg/dL) 0.6±0.1 0.7±0.1 <0.001 0.6±0.1 0.7±0.1 0.040
Uric acid (mg/dL) 4.8±1.4 4.9±1.4 0.051 4.8±1.4 4.8±1.4 0.850
Free fatty acid (mg/dL) 913±60 921±69 0.938 887±58 948±70 0.587
Apolipoprotein A-I (mg/dL) 145±28 139±26 0.157 145±28 138±25 0.099
Apolipoprotein B (mg/dL) 88.8±26.9 80.1±28.6 0.027 88.6±27.1 80.9±30.9 0.091
Lipoprotein A (mg/dL) 20.6±23.1 19.7±22.1 0.684 20.8±23.3 19.3±20.7 0.508
Fibrinogen (mg/dL) 297±84 297±90 0.962 297±85 301±82 0.683
AST (mg/dL) 25.3±19.4 24.5±11.5 0.278 25.5±19.8 24.9±12.5 0.587
ALT (mg/dL) 25.4±26.0 24.7±17.4 0.505 25.6±26.3 23.9±17.5 0.210
ALP (mg/dL) 68.7±22.9 69.9±20.9 0.283 68.6±22.8 70.5±21.5 0.161
CK-MB (ng/dL) 2.6±3.06 3.7±8.0 0.368 2.6±3.09 4.7±10. 0.214
Troponin T (ng/dL) 0.0±0.0 0.0±0.1 0.025 0.0±0.0 0.0±0.1 0.103
B-type natriuretic peptide (ng/dL) 108±225 142±447 0.563 108±225 186±626 0.348

HDL, high density lipoprotein; LDL, low density lipoprotein; CRP, C-reactive protein; AST, aspartate transaminase; ALT, alanine transaminase; ALP, alkaline phosphatase; CK-MB, creatine kinase-MB.